But entrepreneur Rhys Brooking’s world came crashing down when two investors in his company turned out to be drug kingpins. “It was something out of the norm.”He set up a company, New Zealand Fulvic, in 2015. Kirwan stepped away from New Zealand Fulvic in 2018, while Brooking pushed on with developing the product at a plant in his hometown of Kawerau. Care paid Brooking $475,000 in cash, and a further $25,000 was transferred electronically to an account controlled by Brooking. Some of the New Zealand Fulvic shareholders declined to comment when contacted by Stuff.

Source: Stuff July 16, 2021 16:52 UTC